[1] SATOH K,MAKIMURA K, HASUMI Y, et al.Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a japanese hospital[J]. Microbiol Immunol,2009, 53(1): 41-44. [2] DE CÁSSIA ORLANDISARDIJ, SILVA DR, SOARES MENDES-GIANNINI MJ, et al. Candida auris: epidemiology, risk factors, virulence, resistance, and therapeutic options[J]. Microb Pathog, 2018, 125: 116-121. [3] RHODES J, ABDOLRASOULI A, FARRER RA, et al.Genomic epidemiology of the UK outbreak of the emerging human fungal pathogen candida auris[J]. Emerg Microbes Infect, 2018, 7(1): 43. [4] BING J, DU H, GUO P, et al.Candida auris-associated hospitalizations and outbreaks, china, 2018-2023[J]. Emerg Microbes Infect, 2024, 13(1): 2302843. [5] U.S.CENTERS FOR DISEASE CONTROL AND PREVENTION. Tracking C.auris[EB/OL].[2024-12-15]. https://www.cdc.gov/candida-auris/tracking-c-auris/index.html. [6] 廖万清. 医学真菌研究的前沿及热点[J/CD].新发传染病电子杂志, 2018, 3(3):129-133. [7] LEE WG, SHIN JH, UH Y, et al.First three reported cases of nosocomial fungemia caused by Candida auris[J]. J Clin Microbiol, 2011, 49(9): 3139-3142. [8] KIM MN, SHIN JH, SUNG H, et al.Candida haemulonii and closely related species at 5 university hospitals in Korea: identification, antifungal susceptibility, and clinical features[J]. Clin Infect Dis, 2009, 48(6): e57-61. [9] PFALLER MA, DIEKEMA DJ, TURNIDGE JD, et al.Twenty Years of the SENTRY Antifungal Surveillance Program: Results for Candida Species From 1997-2016[J]. Open Forum Infect Dis, 2019, 6(Suppl 1): S79-S94. [10] THE LANCET MICROBE.Candida auris: new clade, same challenges[J]. Lancet Microbe, 2024, 5(9): 100977. [11] MISSERI G, IPPOLITO M, CORTEGIANI A.Global warming “heating up”the ICU through Candida auris infections: the climate changes theory[J]. Crit Care, 2019, 23(1): 416. [12] SUPHAVILAI C, KO KKK, LIM KM, et al.Detection and characterisation of a sixth Candida auris clade in Singapore: a genomic and phenotypic study[J]. Lancet Microbe, 2024, 5(9): 100878. [13] LOCKHART SR, ETIENNE KA, ALLABHANENI S, et al.Simultaneous emergence of multidrug-resistant candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses[J]. Clin Infect Dis, 2017, 64(2): 134-140. [14] MUÑOZ JF, GADE L, CHOW NA, et al. Genomic insights into multidrug-resistance, mating and virulence in Candida auris and related emerging species[J]. Nat Commun, 2018, 9(1): 5346. [15] BORMAN AM, SZEKELY A, JOHNSON EM.Isolates of the emerging pathogen Candida auris present in the UK have several geographic origins[J]. Med Mycol, 2017, 55(5): 563-567. [16] KIM JS, CHA H, BAHN YS.Comprehensive overview of candida auris: an emerging multidrug-resistant fungal pathogen[J]. J Microbiol Biotechnol, 2024, 34(7): 1365-1375. [17] LIONAKIS MS, CHOWDHARY A.Candida auris Infections[J]. N Engl J Med, 2024, 391(20): 1924-1935. [18] BING J, GUAN Z, ZHENG T, et al.Clinical isolates of candida auris with enhanced adherence and biofilm formation due to genomic amplification of ALS4[J]. PLoS Pathog, 2023, 19(3): e1011239. [19] SHARMA SM, SHARMA R, CHANDRATEYA P.Intensification of invasive fungal infections and exploration of effective antifungal drug delivery formulations: a detailed review[J]. Infect Disord Drug Targets, 2024. [20] BROWN GD, DENNING DW, GOW NAR, et al. Hidden Killers: Human Fungal Infections[J]. Sci Transl Med, 2012, 4(165): 165rv13-165rv13. [21] PALLOTTA F, VIALE P, BARCHIESI F.Candida auris: the new fungal threat[J]. Infez Med, 2023, 31(3): 323-328. [22] SANTANA DJ, ANKU JAE, ZHAO G, et al.A Candida auris-specific adhesin, Scf1, governs surface association, colonization, and virulence[J]. Science, 2023, 381(6665): 1461-1467. [23] HERNANDO-ORTIZ A, MATEO E, PEREZ-RODRIGUEZ A, et al.Virulence of candida auris from different clinical origins in caenorhabditis elegans and galleria mellonella host models[J]. Virulence, 2021, 12(1): 1063-1075. [24] HORTON MV, HOLT AM, NETT JE.Mechanisms of pathogenicity for the emerging fungus Candida auris[J]. PLoS Pathog, 2023, 19(12): e1011843. [25] WANG Q, CHENG S, WANG Y, et al.Global characteristics and trends in research on candida auris[J]. Front Microbiol, 2023, 14:1287003. [26] LARKIN E, HAGER C, CHANDRA J, et al.The emerging pathogen candida auris: growth phenotype, virulence factors, activity of antifungals, and effect of SCY-078, a novel glucan synthesis inhibitor, on growth morphology and biofilm formation[J]. Antimicrob Agents Chemother, 2017, 61(5): e02396-16. [27] KEAN R, MCKLOUD E, TOWNSEND EM, et al.The comparative efficacy of antiseptics against Candida auris biofilms[J]. Int J Antimicrob Agents, 2018, 52(5): 673-677. [28] KRIEGL L, EGGER M, BOYER J, et al.New treatment options for critically important WHO fungal priority pathogens[J]. Clin Microbiol Infect, 2024. [29] CHAKRABARTI A, SOOD P, RUDRAMURTHY SM, et al.Incidence, characteristics and outcome of ICU-acquired candidemia in India[J]. Intensive Care Med, 2015, 41(2): 285-295. [30] EYRE DW, SHEPPARD AE, MADDER H, et al.A candida auris outbreak and its control in an intensive care setting[J]. N Engl J Med, 2018, 379(14): 1322-1331. [31] OSEI SEKYERE J.Candida auris: A systematic review and meta-analysis of current updates on an emerging multidrug-resistant pathogen[J]. Microbiologyopen, 2019, 8(8): e00901. [32] PLACHOURAS D, LÖTSCH F, KOHLENBERG A, et al. Candida auris: epidemiological situation, laboratory capacity and preparedness in the European Union and European Economic Area*, January 2018 to May 2019[J]. Euro Surveill, 2020, 25(12): 2000240. [33] BING J, DU H, GUO P, et al.Candida auris-associated hospitalizations and outbreaks, China, 2018-2023[J]. Emerg Microbes Infect, 2024, 13(1): 2302843. [34] MULET BAYONA JV, SALVADOR GARCÍA C, TORMO PALOP N, et al. Evaluation of a novel chromogenic medium for Candida spp. identification and comparison with CHROMagarTM Candida for the detection of Candida auris in surveillance samples[J]. Diagn Microbiol Infect Dis, 2020, 98(4): 115168. [35] GIRARD V, MAILLER S, CHETRY M, et al.Identification and typing of the emerging pathogen Candida auris by matrix-assisted laser desorption ionisation time of flight mass spectrometry[J]. Mycoses, 2016, 59(8):535-538. [36] 邹玉, 陈宗耀, 鄂建飞, 等. 耳念珠菌实验室鉴定方法的研究进展[J]. 中国真菌学杂志, 2022, 17(5): 414-420, 424. [37] BHATTACHARYA S, HOLOWKA T, ORNER EP, et al.Gene Duplication Associated with Increased Fluconazole Tolerance in Candida auris cells of Advanced Generational Age[J]. Sci Rep, 2019, 9(1): 5052. [38] CHOWDHARY A, PRAKASH A, SHARMA C, et al.A multicentre study of antifungal susceptibility patterns among 350 candida auris isolates (2009-17) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance[J]. J Antimicrob Chemother, 2018, 73(4): 891-899. [39] 中国成人念珠菌病诊断与治疗专家共识组. 中国成人念珠菌病诊断与治疗专家共识[J]. 中华传染病杂志, 2020, 38(1): 29-43. [40] BORGIO JF, ALHUJAILY R, ALFARAJ AS, et al.Genome-guided identification of surfactin-producing bacillus halotolerans AQ11M9 with anti-candida auris potential[J]. Int J Mol Sci, 2024, 25(19): 10408. [41] ARENDRUP MC, JØRGENSEN KM, HARE RK, et al. In Vitro Activity of Ibrexafungerp (SCY-078) against Candida auris Isolates as Determined by EUCAST Methodology and Comparison with Activity against C. albicans and C. glabrata and with the Activities of Six Comparator Agents[J]. Antimicrob Agents Chemother, 2020, 64(3): e02136-19. [42] TETZ G, COLLINS M, VIKINA D, et al.In vitro activity of a novel antifungal compound, MYC-053, against clinically significant antifungal-resistant strains of candida glabrata, candida auris, cryptococcus neoformans, and pneumocystis spp[J]. Antimicrob Agents Chemother, 2019, 63(4): e01975-18. [43] PIEDRAHITA CT, CADNUM JL, JENCSON AL, et al.Environmental surfaces in healthcare facilities are a potential source for transmission of candida auris and other candida species[J]. Infect Control Hosp Epidemiol, 2017, 38(9): 1107-1109. [44] FORSBERG K, WOODWORTH K, WALTERS M, et al.Candida auris : The recent emergence of a multidrug-resistant fungal pathogen[J]. Med Mycol, 2019, 57(1): 1-12. [45] 黄劲华, 孔旭辉, 丁滢, 等. 葡萄糖酸氯己定擦浴预防ICU患者多重耐药菌感染[J]. 中国感染控制杂志, 2018, 17(3): 252-255. |